- Home
- ARWR vs RITM Comparison
ARWR vs RITM Comparison
Compare ARWR & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | RITM |
|---|---|---|
| Founded | 2001 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.4B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | RITM |
|---|---|---|
| Price | $58.23 | $11.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $55.50 | $14.25 |
| AVG Volume (30 Days) | 2.5M | ★ 6.0M |
| Earning Date | 11-25-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 8.73% |
| EPS Growth | N/A | ★ 46.96 |
| EPS | N/A | ★ 1.45 |
| Revenue | $829,448,000.00 | ★ $3,961,432,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.75 |
| P/E Ratio | ★ N/A | $7.90 |
| Revenue Growth | ★ 23258.15 | 32.03 |
| 52 Week Low | $9.57 | $9.13 |
| 52 Week High | $59.15 | $12.74 |
Technical Indicators
Market Signals| Indicator | ARWR | RITM |
|---|---|---|
| Relative Strength Index (RSI) | 74.49 | 54.92 |
| Support Level | $37.06 | $10.72 |
| Resistance Level | $59.15 | $11.61 |
| Average True Range (ATR) | 3.92 | 0.19 |
| MACD | 1.64 | 0.06 |
| Stochastic Oscillator | 90.86 | 63.84 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.